These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5271994)

  • 21. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I
    Scand J Respir Dis Suppl; 1970; 71():192-5. PubMed ID: 5271985
    [No Abstract]   [Full Text] [Related]  

  • 22. General survey of the clinical results of treatment of pulmonary tuberculosis with cycloserine in Turkey.
    Ozgen ZS
    Scand J Respir Dis Suppl; 1970; 71():189-91. PubMed ID: 5271984
    [No Abstract]   [Full Text] [Related]  

  • 23. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficiency of cycloserine in association with other tuberculostatics.
    Anastasatu C; Ulpian C; Weiss P
    Scand J Respir Dis Suppl; 1970; 71():152-4. PubMed ID: 5271976
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of combined use of cycloserine in pulmonary tuberculosis.
    Tello F
    Scand J Respir Dis Suppl; 1970; 71():162-7. PubMed ID: 5271979
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secondary antitubercular drugs in the treatment of childhood tuberculosis].
    de Lacerda A
    Rev Port Pediatr Pueric; 1967 May; 30(5):149-56. PubMed ID: 4303078
    [No Abstract]   [Full Text] [Related]  

  • 29. On the treatment of primary tuberculosis in tender age (0-5 years) with resistomycin, cycloserine, and ethionamid.
    Dobrev P; Slaveykova A; Lankova D
    Nauchni Tr Vissh Med Inst Sofiia; 1966; 45(5):37-42. PubMed ID: 4228990
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of cycloserine in different chemotherapy combinations on chronic pulmonary tuberculosis.
    Susteric J
    Scand J Respir Dis Suppl; 1970; 71():159-61. PubMed ID: 5271978
    [No Abstract]   [Full Text] [Related]  

  • 31. Cycloserine plus ethionamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Devadatta S; Evans C; Kamat SR; Menon NK; Radhakrishna S; Rajagopalan S; Stott H; Tripathy SP; Velu S
    Tubercle; 1967 Jun; 48(2):114-27. PubMed ID: 6048655
    [No Abstract]   [Full Text] [Related]  

  • 32. [Problems of post-sanatorial antimycobacterial treatment].
    Corda M
    Minerva Med; 1965 Sep; 56(70):2827-31. PubMed ID: 5852641
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN; Gur'ian IE; Kochetov BI
    Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of drugs of secondary group in complex therapy of children with chronic tuberculosis].
    Rushchak VA
    Pediatr Akus Ginekol; 1971; 2():24-5. PubMed ID: 4254375
    [No Abstract]   [Full Text] [Related]  

  • 36. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 37. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of 2d series tuberculostatic preparations for pulmonary tuberculosis patients under outpatient conditions].
    Oifabakh MI; Simonian LK
    Probl Tuberk; 1969; 47(11):16-20. PubMed ID: 5369220
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.